Citations

Mayo Clinic

Showing 10 of 108599 citations.

Does Alcohol Use Influence Hospitalization Outcomes in Adults Suffering Craniomaxillofacial Fractures From Street Fighting?
Stanbouly, Dani , Stewart, Sara J., Arce, Kevin , Harris, Jack A.

Craniomaxillofacial Trauma & Reconstruction | June 2, 2023 | Volume: 17 | Issue: 2 | Pages: 132-142

10.1177/19433875231164705 | PMID 38779398 Get It

Study Design This retrospective cohort study utilized the National Inpatient Sample (NIS) database for the years 2016–2018. Incidences of street fighting were identified using the corresponding ICD-10 codes. Objective To determine whether alcohol use (measured by blood alcohol content (BAC)) in patients sustaining maxillofacial trauma from hand-to-hand fighting influence hospitalization outcomes. Methods The primary predictor variable was BAC stratified into six categories of increasing magnitude. The primary outcome variable was mean length of hospital stay (days). The secondary outcome variable was total hospital charges (US dollars). Results Our final sample consisted of 3038 craniomaxillofacial fractures. Each additional year in age added +$545 in hospital charges ( P < .01). Non-elective admissions added $14 210 in hospital charges ( P < .05). Patients admitted in 2018 experienced approximately $7537 more in hospital charges ( P < .01). Le Fort fractures (+$61 921; P < .01), mandible fractures (+$13 227, P < .01), and skull base fractures (+$22 170; P < .05) were all independently associated with increased hospital charges. Skull base fractures added +7.6 days to the hospital stay ( P < .01) and each additional year in patient age added +.1 days to the length of the hospital stay ( P < .01). Conclusions BAC levels did not increase length of stay or hospitalization charges. Le Fort fractures, mandible fractures, and skull base fracture each independently increased hospital charges. This reflects the necessary care (ie, ICU) and treatment (ie, ORIF) of such fractures. Older adults and elderly patients are associated with increased length of stay and hospital charges—they are likely to struggle in navigating the healthcare system and face socioeconomic barriers to discharge.
A prospective multicenter study to evaluate the impact of cryotherapy on dysphagia and quality of life in patients with inoperable esophageal cancer
Kachaamy, Toufic , Sharma, Neil S, Shah, Tilak , Mohapatra, Sonmoon , Zelt, Christina , Jewett, Elaine, Garcia, Rigoberto, Munsey, Rachel, Gupta, Saurabh , Rojas-DeLeon, Mariajose, Pannala, Rahul , Vashi, Pankaj G., Sharma, Neil, Pollard, Kimberly, Gupta, Digant , Kaul, Vivek

Endoscopy | June 2, 2023 | Volume: 55 | Issue: 10 | Pages: 889-897

10.1055/a-2105-2177 | PMID 37268010 Get It

Background Dysphagia palliation in inoperable esophageal cancer continues to be a challenge. Self-expandable metal stents have been the mainstay of endoscopic palliation but have a significant risk of adverse events (AEs). Liquid nitrogen spray cryotherapy is an established modality that can be used with systemic therapy. This study reports the outcomes of cryotherapy, including dysphagia and quality of life (QoL), in patients receiving systemic therapy. Methods This was a prospective multicenter cohort study of adults with inoperable esophageal cancer who underwent cryotherapy. QoL and dysphagia scores before and after cryotherapy were compared. Results 55 patients received 175 cryotherapy procedures. After a mean of 3.2 cryotherapy sessions, mean QoL improved from 34.9 at baseline to 29.0 at last follow-up (P < 0.001) and mean dysphagia improved from 1.9 to 1.3 (P = 0.004). Patients receiving more intensive cryotherapy (≥ 2 treatments within 3 weeks) showed a significantly greater improvement in dysphagia compared with those not receiving intensive therapy (1.2 vs. 0.2 points; P = 0.003). Overall, 13 patients (23.6 %) received another intervention (1 botulinum toxin injection, 2 stent, 3 radiation, 7 dilation) for dysphagia palliation. Within the 30-day post-procedure period, there were three non-cryotherapy-related grade ≥ 3 AEs (all deaths). The median overall survival was 16.4 months. Conclusion In patients with inoperable esophageal cancer receiving concurrent systemic therapy, adding liquid nitrogen spray cryotherapy was safe and associated with improvement in dysphagia and QoL without causing reflux. More intensive treatment showed a greater improvement in dysphagia and should be considered as the preferred approach.
Systematic design and data-driven evaluation of social determinants of health ontology (SDoHO)
Dang, Yifang , Li, Fang , Hu, Xinyue , Keloth, Vipina K. , Zhang, Meng , Fu, Sunyang , Amith, Muhammad , Fan, J Wilfred, Du, Jingcheng , Jiang, Xiaoqian , Xu, Hua , Fan, Jungwei , Amith, Muhammad F , Liu, Hongfang , Jiang, Xiaoqian , Xu, Hua , Fan, Jungwei , Fu, Sunyang , Dang, Yifang , Li, Fang , Keloth, Vipina K , Fan, J Wilfred, Yu, Evan, Liu, Hongfang , Tao, Cui

Journal of the American Medical Informatics Association | June 2, 2023 | Volume: 30 | Issue: 9 | Pages: 1465-1473

10.1093/jamia/ocad096 | PMID 37301740 Get It

Abstract Objective Social determinants of health (SDoH) play critical roles in health outcomes and well-being. Understanding the interplay of SDoH and health outcomes is critical to reducing healthcare inequalities and transforming a “sick care” system into a “health-promoting” system. To address the SDOH terminology gap and better embed relevant elements in advanced biomedical informatics, we propose an SDoH ontology (SDoHO), which represents fundamental SDoH factors and their relationships in a standardized and measurable way. Material and Methods Drawing on the content of existing ontologies relevant to certain aspects of SDoH, we used a top-down approach to formally model classes, relationships, and constraints based on multiple SDoH-related resources. Expert review and coverage evaluation, using a bottom-up approach employing clinical notes data and a national survey, were performed. Results We constructed the SDoHO with 708 classes, 106 object properties, and 20 data properties, with 1,561 logical axioms and 976 declaration axioms in the current version. Three experts achieved 0.967 agreement in the semantic evaluation of the ontology. A comparison between the coverage of the ontology and SDOH concepts in 2 sets of clinical notes and a national survey instrument also showed satisfactory results. Discussion SDoHO could potentially play an essential role in providing a foundation for a comprehensive understanding of the associations between SDoH and health outcomes and paving the way for health equity across populations. Conclusion SDoHO has well-designed hierarchies, practical objective properties, and versatile functionalities, and the comprehensive semantic and coverage evaluation achieved promising performance compared to the existing ontologies relevant to SDoH.
Unexpected discovery of a bicuspid pulmonary valve on 3D transoesophageal echocardiography
Lee, Hong S, Apolinario, Michael , Farina, Juan M. , Arsanjani, Reza , Apolinario, Michael A, Arsanjani, Reza , Farina, Juan M , Majdalany, David S

European Heart Journal - Cardiovascular Imaging | June 2, 2023 | Volume: 24 | Issue: 9 | Pages: e271-e271

10.1093/ehjci/jead127 | PMID 37267328 Get It

Characteristics and prognostic impact ofIDHmutations in AML: a COG, SWOG, and ECOG analysis
Zarnegar‐Lumley, Sara , Gerbing, Robert B., Sun, Zhuoxin , Kutny, Matthew A. , Ostronoff, Fabiana , Radich, Jerald P. , Appelbaum, Frederick R. , Pogosova‐Agadjanyan, Era L. , O’Dwyer, Kristen M. , Tallman, Martin S. , Litzow, Mark R. , Cooper, Todd M. , Aplenc, Richard , Gamis, Alan S. , Luger, Selina M. , Stirewalt, Derek L. , Tarlock, Katherine , Pogosova-Agadjanyan, Era L , Litzow, Mark R. , Gamis, Alan S , Erba, Harry Paul , Alonzo, Todd A. , Othus, Megan , Ries, Rhonda E. , Wang, Jim, Leonti, Amanda R. , O'Dwyer, Kristin , Atallah, Ehab , Abdel‐Wahab, Omar , Levine, Ross L. , Kolb, E Anders , Meshinchi, Soheil

Blood Advances | June 2, 2023 | Volume: 7 | Issue: 19 | Pages: 5941-5953

10.1182/bloodadvances.2022008282 | PMID 37267439 Get It

AbstractSomatic mutations in isocitrate dehydrogenase (IDH) genes occur frequently in adult acute myeloid leukemia (AML) and less commonly in pediatric AML. The objective of this study was to describe the prevalence, mutational profile, and prognostic significance of IDH mutations in AML across age. Our cohort included 3141 patients aged between &lt;1 month and 88 years treated on Children’s Cancer Group/Children’s Oncology Group (n = 1872), Southwest Oncology Group (n = 359), Eastern Cooperative Oncology Group (n = 397) trials, and in Beat AML (n = 333) and The Cancer Genome Atlas (n = 180) genomic characterization cohorts. We retrospectively analyzed patients in 4 age groups (age range, n): pediatric (0-17, 1744), adolescent/young adult (18-39, 444), intermediate-age (40-59, 640), older (≥60, 309). IDH mutations (IDHmut) were identified in 9.2% of the total cohort (n = 288; IDH1 [n = 123, 42.7%]; IDH2 [n = 165, 57.3%]) and were strongly correlated with increased age: 3.4% pediatric vs 21% older, P &lt; .001. Outcomes were similar in IDHmut and IDH-wildtype (IDHWT) AML (event-free survival [EFS]: 35.6% vs 40.0%, P = .368; overall survival [OS]: 50.3% vs 55.4%, P = .196). IDH mutations frequently occurred with NPM1 (47.2%), DNMT3A (29.3%), and FLT3-internal tandem duplication (ITD) (22.4%) mutations. Patients with IDHmut AML with NPM1 mutation (IDHmut/NPM1mut) had significantly improved survival compared with the poor outcomes experienced by patients without (IDHmut/NPM1WT) (EFS: 55.1% vs 17.0%, P &lt; .001; OS: 66.5% vs 35.2%, P &lt; .001). DNTM3A or FLT3-ITD mutations in otherwise favorable IDHmut/NPM1mut AML led to inferior outcomes. Age group analysis demonstrated that IDH mutations did not abrogate the favorable prognostic impact of NPM1mut in patients aged &lt;60 years; older patients had poor outcomes regardless of NPM1 status. These trials were registered at www.clinicaltrials.gov as #NCT00070174, #NCT00372593, #NCT01371981, #NCT00049517, and #NCT00085709.
Rho-associated protein kinase 1 inhibition in hepatocytes attenuates nonalcoholic steatohepatitis
Dohnálková, Ester , Bayer, Rachel L., Guo, Qianqian , Lee, Hyun Se Kim , Valenzuela-Pérez, Lucía , Krishnan, Anuradha , Pavelko, Kevin D. , Guisot, Nicolas E. S. , Bunyard, Peter, Ibrahim, Samar H. , Bamidele, Adebowale O , Kim Lee, Hyun Se , Pavelko, Kevin D , Kim, Young-Bum , Ibrahim, Samar H , Hirsova, Petra , Guo, Qianqian , Bamidele, Adebowale O. , Gores, Gregory J. , Valenzuela-Pérez, Lucía

Hepatology Communications | June 2, 2023 | Volume: 7 | Issue: 6 | Pages: No page available

10.1097/hc9.0000000000000171 | PMID 37267252 Get It

Background: NASH is the progressive form of NAFLD characterized by lipotoxicity, hepatocyte injury, tissue inflammation, and fibrosis. Previously, Rho-associated protein kinase (ROCK) 1 has been implicated in lipotoxic signaling in hepatocytes in vitro and high-fat diet-induced lipogenesis in vivo. However, whether ROCK1 plays a role in liver inflammation and fibrosis during NASH is unclear. Here, we hypothesized that pathogenic activation of ROCK1 promotes murine NASH pathogenesis. Methods and Results: Patients with NASH had increased hepatic ROCK1 expression compared with patients with fatty liver. Similarly, hepatic ROCK1 levels and activity were increased in mice with NASH induced by a western-like diet that is high in fat, fructose, and cholesterol (FFC). Hepatocyte-specific ROCK1 knockout mice on the FFC diet displayed a decrease in liver steatosis, hepatic cell death, liver inflammation, and fibrosis compared with littermate FFC-fed controls. Mechanistically, these effects were associated with a significant attenuation of myeloid cell recruitment. Interestingly, myeloid cell-specific ROCK1 deletion did not affect NASH development in FFC-fed mice. To explore the therapeutic opportunities, mice with established NASH received ROCKi, a novel small molecule kinase inhibitor of ROCK1/2, which preferentially accumulates in liver tissue. ROCK inhibitor treatment ameliorated insulin resistance and decreased liver injury, inflammation, and fibrosis. Conclusions: Genetic or pharmacologic inhibition of ROCK1 activity attenuates murine NASH, suggesting that ROCK1 may be a therapeutic target for treating human NASH.
Rethinking the clinical utility of distortion-product otoacoustic emission (DPOAE) signal-to-noise ratio
Portugal, Nicholas, Poling, Gayla L. , Dreisbach, Laura

International Journal of Audiology | June 2, 2023 | Volume: 63 | Issue: 7 | Pages: 491-499

10.1080/14992027.2023.2215943 | PMID 37267054 Get It

“Autoimmune HIT” antibodies in diagnostic samples are a potential artifact and not associated with more severe outcomes
Kanack, Adam J. , Athale, Janhavi, Leger, Rachel, Saadalla, A, Heikal, Nahla, García, David , Pruthi, Rajiv K. , Padmanabhan, Anand , Leger, Rachel R, Heikal, Nahla M, Padmanabhan, Anand , Chen, Dong , Singh, Ravinder J.

Blood Advances | June 2, 2023 | Volume: 7 | Issue: 16 | Pages: 4431-4434

10.1182/bloodadvances.2023009811 | PMID 37267446 Get It

ABO blood group type and risk of venous thrombosis in essential thrombocythemia
Karrar, Omer , Abdelmagid, Maymona, Vannucchi, Alessandro M. , Barbui, Tiziano , Tefferi, Ayalew , Gangat, Naseema , Karrar, Omer S, Vannucchi, Alessandro M

British Journal of Haematology | June 2, 2023 | Volume: 202 | Issue: 3 | Pages: 699-703

10.1111/bjh.18906 | PMID 37265027 Get It